A Longitudinal Prospective Study Evaluating the Effects of Eltrombopag Treatment On Bone Marrow in Patients with Chronic Immune Thrombocytopenia: Interim Analysis At 1 Year

Abstract 2195 Eltrombopag (epag), a thrombopoietin receptor agonist (TPO-RA), increases platelet counts in patients with chronic immune thrombocytopenia (cITP). TPO-RAs have been associated with varying degrees of increases in bone marrow reticulin (Brynes 2011; Ghanima 2011). Due to lack of pretrea...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 120; no. 21; p. 2195
Main Authors Brynes, Russell K., Orazi, Attilio, Wong, Raymond S.M., Bakshi, Kalpana, Bailey, Christine K, Brainsky, Andres
Format Journal Article
LanguageEnglish
Published Elsevier Inc 16.11.2012
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first